NCT04268199TerminatedPhase 2
A Multicentre, Non-Blinded Study Exploring Self-Administration of Chemotherapy in the Home Environment
Source: ClinicalTrials.gov · Last updated 28 Oct 2026
Reason given: Operational limitations
Brief summary (registry, in English)
This study is to see if the standard of care subcutaneous injection of bortezomib can safely be administered at home by the patient or caregiver. All tests and assessments are based on standard of care procedures.
- Status (registry)
- Terminated
- Phase (registry)
- Phase 2
- Study type
- Interventional
- Enrollment
- 39 (actual)
- First submitted
- 10 Feb 2020
- Start date
- 29 May 2020
- Primary completion date
- 31 Aug 2026
- Lead sponsor
- AHS Cancer Control Alberta
- Diseases
- Multiple myeloma
- NCT number
- NCT04268199
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Clinically deemed unlikely to be compliant with therapy by responsible investigator,
Other illness
- History of allergic reactions to bortezomib,
- History of bleeding attributable to bortezomib,
- History of greater than or equal to grade 3 side effects attributable to bortezomib,
Other
- Currently participating in clinical trials that includes the use of bortezomib,
- Life expectancy anticipated to be less than 6 months,
- Deemed geographically inaccessible to receive care.
Who the study is looking for
- Patients are aged 18 years old or older with a diagnosis of symptomatic myeloma,
- Stable clinical status as deemed by responsible investigator,
- Personally (or caregiver) willing and deemed capable to self-administer with teaching,
- Previously received more than 4 injections of bortezomib within the hospital and/or cancer centre environment,
- Signed informed consent.
Age in the registry: 18 years to - · Sex: All · Does not accept healthy volunteers
Sites (2)
Sites in registry order. Save your city in your profile to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Arthur J.E. Child Comprehensive Cancer Centre | Calgary | Canada | Unknown status |
| Cross Cancer Institute | Edmonton | Canada | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.